Ahmed, Asma; Reinhold, Cindy; Breunig, Eileen; Phan, Truong San; Dietrich, Lea; Kostadinova, Feodora; Urwyler, Corinne; Merk, Verena M; Noti, Mario; Toja da Silva, Israel; Bode, Konstantin; Nahle, Fatima; Plazzo, Anna Pia; Koerner, Julia; Stuber, Regula; Menche, Constantin; Karamitopoulou, Evanthia; Farin, Henner F; Gollob, Kenneth J and Brunner, Thomas (2023). Immune escape of colorectal tumors via local LRH-1/Cyp11b1-mediated synthesis of immunosuppressive glucocorticoids. Molecular oncology, 17(8), pp. 1545-1566. FEBS Press 10.1002/1878-0261.13414
|
Text
Molecular_Oncology_-_2023_-_Ahmed_-_Immune_escape_of_colorectal_tumors_via_local_LRH_1_Cyp11b1_mediated_synthesis_of.pdf - Accepted Version Available under License Creative Commons: Attribution (CC-BY). Download (9MB) | Preview |
Control of tumor development and growth by the immune system critically defines patient fate and survival. What regulates the escape of colorectal tumors from destruction by the immune system is currently unclear. Here, we investigated the role of intestinal synthesis of glucocorticoids in the tumor development during inflammation-induced mouse model of colorectal cancer. We demonstrate that the local synthesis of immunoregulatory glucocorticoids has dual roles in the regulation of intestinal inflammation and tumor development. In the inflammation phase LRH-1/Nr5A2-regulated and Cyp11b1-mediated intestinal glucocorticoid synthesis prevents tumor development and growth. In established tumors, however, tumor-autonomous Cyp11b1-mediated glucocorticoid synthesis suppresses anti-tumor immune responses and promotes immune escape. Transplantation of glucocorticoid synthesis-proficient colorectal tumor organoids into immunocompetent recipient mice resulted in rapid tumor growth, whereas transplantation of Cyp11b1-deleted and glucocorticoid synthesis-deficient tumor organoids was characterized by reduced tumor growth and increased immune cell infiltration. In human colorectal tumors, high expression of steroidogenic enzymes correlated with the expression of other immune checkpoints and suppressive cytokines, and negatively correlated with overall patients' survival. Thus, LRH-1-regulated tumor-specific glucocorticoid synthesis contributes to tumor immune escape and represents a novel potential therapeutic target.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Service Sector > Institute of Pathology 04 Faculty of Medicine > Service Sector > Institute of Pathology > Immunopathology |
UniBE Contributor: |
Noti, Mario, Stuber Roos, Regula, Karamitopoulou Diamantis, Evanthia |
Subjects: |
500 Science > 570 Life sciences; biology 600 Technology > 610 Medicine & health |
ISSN: |
1878-0261 |
Publisher: |
FEBS Press |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
06 Mar 2023 09:06 |
Last Modified: |
04 Aug 2023 00:13 |
Publisher DOI: |
10.1002/1878-0261.13414 |
PubMed ID: |
36861295 |
Uncontrolled Keywords: |
CYP11B1 Colorectal cancer Liver Receptor Homolog-1 (NR5A2) glucocorticoids immune checkpoint tumor immune escape |
BORIS DOI: |
10.48350/179463 |
URI: |
https://boris.unibe.ch/id/eprint/179463 |